David Rimm, Ph.D.

Southern Illinois University at Carbondale, Carbondale, IL 
"David Rimm"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shafi S, Aung TN, Xirou V, et al. (2022) Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology
Ahmed FS, Gaule P, McGuire J, et al. (2020) PD-L1 protein expression on both tumor cells and macrophages are associated with response to neoadjuvant durvalumab in triple negative breast cancer (TNBC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Ding A, Villarroel-Espindola F, Ducler A, et al. (2020) Abstract 5525: VISTA/PSGL1 axis as a dominant immunomodulatory pathway in human non-small cell lung cancer Immunology. 80: 5525-5525
Pelekanou V, Carvajal-Hausdorf DE, Altan M, et al. (2017) Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance. Breast Cancer Research : Bcr. 19: 91
Wimberly H, Han G, Pinnaduwage D, et al. (2014) ERβ splice variant expression in four large cohorts of human breast cancer patient tumors. Breast Cancer Research and Treatment. 146: 657-67
Jeon YJ, Khelifa S, Feng Y, et al. (2014) Abstract 2440: RNF5 mediates ER stress-induced degradation of SLC1A5 in breast cancer Cancer Research. 74: 2440-2440
Michal AM, Peck AR, Tran TH, et al. (2011) Differential expression of arrestins is a predictor of breast cancer progression and survival. Breast Cancer Research and Treatment. 130: 791-807
Peck A, Witkiewicz A, Liu C, et al. (2011) P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome. Cancer Research. 71
Neumeister V, Agarwal S, Bordeaux J, et al. (2010) In Situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis American Journal of Pathology. 176: 2131-2138
Nadler Y, González AM, Camp RL, et al. (2010) Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 466-73
See more...